Top Markets
Coin of the day
Microba Life Sciences Limited Microba Life Sciences Limited

Microba Life Sciences Limited

MAP
Rang in aandelen #28052
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
Aandeelprijs
$0.04020123
Marktkapitalisatie
$28.83M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-31.34%
Land
AU
Handel Microba Life Sciences Limited (MAP)

Categorie

Dividendrendementgeschiedenis voor Microba Life Sciences Limited (MAP)
Het dividendrendement (TTM) van Microba Life Sciences Limited (aandelsymbool: MAP) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Microba Life Sciences Limited (MAP) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten